Brinker Capital Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Sell |
15,554
-5,512
| -26% | -$431K | 0.01% | 1077 |
|
|
2025
Q1 | $1.53M | Sell |
21,066
-492
| -2% | -$35.7K | 0.02% | 858 |
|
|
2024
Q4 | $1.6M | Sell |
21,558
-8,974
| -29% | -$664K | 0.02% | 806 |
|
|
2024
Q3 | $2.01M | Buy |
+30,532
| New | +$2.01M | 0.02% | 685 |
|
|
2023
Q3 | – | Sell |
-42,298
| Closed | -$3.99M | – | 1633 |
|
|
2023
Q2 | $3.99M | Sell |
42,298
-6,433
| -13% | -$607K | 0.04% | 379 |
|
|
2023
Q1 | $4.03M | Buy |
48,731
+2,136
| +5% | +$177K | 0.05% | 324 |
|
|
2022
Q4 | $3.48M | Buy |
46,595
+4,036
| +9% | +$301K | 0.07% | 282 |
|
|
2022
Q3 | $3.52M | Sell |
42,559
-1,254
| -3% | -$104K | 0.07% | 268 |
|
|
2022
Q2 | $4.17M | Sell |
43,813
-3,075
| -7% | -$292K | 0.08% | 244 |
|
|
2022
Q1 | $5.52M | Sell |
46,888
-1,279
| -3% | -$151K | 0.08% | 233 |
|
|
2021
Q4 | $6.24M | Sell |
48,167
-888
| -2% | -$115K | 0.09% | 222 |
|
|
2021
Q3 | $5.08M | Hold |
49,055
| – | – | 0.08% | 257 |
|
|
2021
Q2 | $5.08M | Buy |
49,055
+1,232
| +3% | +$128K | 0.07% | 300 |
|
|
2021
Q1 | $4M | Sell |
47,823
-46,276
| -49% | -$3.87M | 0.06% | 306 |
|
|
2020
Q4 | $8.59M | Buy |
94,099
+44,081
| +88% | +$4.02M | 0.13% | 175 |
|
|
2020
Q3 | $3.99M | Buy |
+50,018
| New | +$3.99M | 0.07% | 286 |
|
|
2019
Q3 | – | Sell |
-1,548
| Closed | -$95K | – | 805 |
|
|
2019
Q2 | $95K | Buy |
1,548
+558
| +56% | +$34.2K | ﹤0.01% | 491 |
|
|
2019
Q1 | $63K | Buy |
+990
| New | +$63K | ﹤0.01% | 424 |
|
|
2018
Q3 | – | Sell |
-180
| Closed | -$9K | – | 648 |
|
|
2018
Q2 | $9K | Buy |
+180
| New | +$9K | ﹤0.01% | 497 |
|